Neuphoria Therapeutics (NEUP) Leases (2021 - 2025)
Historic Leases for Neuphoria Therapeutics (NEUP) over the last 3 years, with Q3 2025 value amounting to $75219.0.
- Neuphoria Therapeutics' Leases fell 6190.42% to $75219.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $75219.0, marking a year-over-year decrease of 6190.42%. This contributed to the annual value of $102612.0 for FY2025, which is N/A changed from last year.
- Per Neuphoria Therapeutics' latest filing, its Leases stood at $75219.0 for Q3 2025, which was down 6190.42% from $102612.0 recorded in Q2 2025.
- Over the past 5 years, Neuphoria Therapeutics' Leases peaked at $549878.2 during Q4 2021, and registered a low of $75219.0 during Q3 2025.
- For the 3-year period, Neuphoria Therapeutics' Leases averaged around $200148.0, with its median value being $137866.0 (2024).
- Within the past 5 years, the most significant YoY rise in Neuphoria Therapeutics' Leases was 6190.42% (2025), while the steepest drop was 6190.42% (2025).
- Quarter analysis of 3 years shows Neuphoria Therapeutics' Leases stood at $549878.2 in 2021, then tumbled by 72.63% to $150519.0 in 2024, then crashed by 50.03% to $75219.0 in 2025.
- Its Leases stands at $75219.0 for Q3 2025, versus $102612.0 for Q2 2025 and $125213.0 for Q1 2025.